# Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

> **NCT05961956** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Novadip Biosciences** · enrollment: 5 (actual)

## Conditions studied

- Degenerative Lumbar Spondylolisthesis

## Interventions

- **DRUG:** NVDX3

## Key facts

- **NCT ID:** NCT05961956
- **Lead sponsor:** Novadip Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-12
- **Primary completion:** 2026-04-18
- **Final completion:** 2026-04-18
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961956, "Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05961956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*